Insulin Resistance
insulin resistance is when
cells in your muscles, fat, and liver don’t respond well to insulin and can’t easily take up glucose from your blood. As a result, your pancreas makes more insulin to help glucose enter your cells. As long as your pancreas can make enough insulin to overcome your cells’ weak response to insulin, your blood glucose levels will stay in the healthy range.
People who have genetic or lifestyle risk factors are more likely to develop
insulin resistance or prediabetes. Risk factors include
· overweight or obesity
· age 45 or older
· a parent, brother, or sister with diabetes
· African American, Alaska Native, American Indian, Asian American, Hispanic/Latino, Native Hawaiian, or Pacific Islander American ethnicity
· physical inactivity
·
health conditions such as
high blood pressure and abnormal cholesterol levels
· a
history of gestational diabetes
· a
history of heart disease or stroke
· polycystic ovary syndrome, also called PCOS
People who have metabolic syndrome—a combination of high blood pressure, abnormal cholesterol levels, and large waist size—are more likely to have prediabetes.
Along with these risk factors, other things that may contribute to
insulin resistance include
· certain medicines, such as glucocorticoids NIH external link, some antipsychotics NIH external link, and some medicines for HIV NIH external link
· hormonal disorders, such as Cushing’s
syndrome and acromegaly
· sleep problems, especially sleep apnea
High Impact List of Articles
-
Effect of discharge plan on patients readiness to discharge after allogeneic stem cells transplantation
Shaimaa Raafat Ali, Khairia Abo Bakr Elsawi, Hanaa Youssry Hashem & Gamal Eldin Mohammed Fathy
Research Article: Clinical Practice
-
Effect of discharge plan on patients readiness to discharge after allogeneic stem cells transplantation
Shaimaa Raafat Ali, Khairia Abo Bakr Elsawi, Hanaa Youssry Hashem & Gamal Eldin Mohammed Fathy
Research Article: Clinical Practice
-
Blood biomarkers to identify ischemic stroke etiologies
Teresa Garcia-Berrocoso, Israel Fernandez-Cadenas, Pilar Delgado, Anna Rosell and Joan Montaner
Review Article: Clinical Practice
-
Blood biomarkers to identify ischemic stroke etiologies
Teresa Garcia-Berrocoso, Israel Fernandez-Cadenas, Pilar Delgado, Anna Rosell and Joan Montaner
Review Article: Clinical Practice
-
Oophorectomy as a preventative measure for ovarian cancer
Mary B Daly
Review Article: Clinical Practice
-
Oophorectomy as a preventative measure for ovarian cancer
Mary B Daly
Review Article: Clinical Practice
-
Kogenate R FS: antihemophilic factor rFVIII-FS
Jeanne Lusher and Meera Chitlur
Drug Evaluation: Clinical Practice
-
Kogenate R FS: antihemophilic factor rFVIII-FS
Jeanne Lusher and Meera Chitlur
Drug Evaluation: Clinical Practice
-
Cardiovascular safety of COX-2 inhibition: Time to inform systems of postmarketing surveillance?
Robert J MacFadyen and Thomas M MacDonald
Editorial: Clinical Practice
-
Cardiovascular safety of COX-2 inhibition: Time to inform systems of postmarketing surveillance?
Robert J MacFadyen and Thomas M MacDonald
Editorial: Clinical Practice
Relevant Topics in Clinical